Guest Blog From @NerdElert – PESI Monopoly on a Multi-Billion Dollar Medical Isotope Market

It’s all about Technetium-99m (Tc-99m), the most widely used and expensive medical isotope in the world.  Tc-99m is the critical isotope behind the over 25 million diagnostic nuclear medical procedures in the U.S. alone.  Cancer detection, gastrointestinal tract analysis, and imaging of the brain, kidneys, and spleen are just some of the procedures that rely […]

Read More

PME Guided To $1 EPS In 2014 And The Comparable Industry P/E Is 17

Please see DISCLAIMER at the end of this article Pingtan Marine Enterprise Ltd. (PME), (“Pingtan,” or the “Company”) a global fishing company based in the People’s Republic of China (PRC),  announced financial results for its fourth quarter and year ended December 31, 2013. Current Results Revenue from continuing operations (the “fishing business”) increased 81.8% to $122.7 […]

Read More

Why Harvard Apparatus Regenerative Technology Is Undervalued As They One Day Seek To Eliminate The Need For Organ Donors

Read the Disclosure at the bottom of this article. Shares of Harvard Apparatus Regenerative Technology (HART) closed at $8.87 on March 5, 2014. That is a market capitalization of $71 million (8 million shares outstanding). Of the nine public traded companies that are working on regenerative medicine or organ replication, the smallest and largest closed […]

Read More

GE To Spend $1.4 Billion On Distributed Power – SYMX Is Working With GE On Distributed Power Per Their Press Release

I bought and gave a buy alert to my subscribers (click here to subscribe to my service and click here to register for my Super Trade BootCamp)  on SYMX yesterday at $1.56 because there were numerous articles on Chinese pollution becoming unbearable and on February 14th this headline was out there : SYMX and Zhangjiagang Chemical […]

Read More